TACE术联合自体CIK细胞治疗原发性肝癌  

TACE Combined with Autologous CIK Cells Treatment on Hepatocellular Carcinoma

作　　者：王福立[1] 李岩[1] 梁婧[1] 刘海荣[1] 刘晓琳[1] 肖俊娟[1] 商伟菊[1] 

机构地区：[1]山东大学附属千佛山医院肿瘤科,山东济南250014

出　　处：《医学与哲学（B）》2011年第4期27-28,33,共3页Medicine & Philosophy(B)

摘　　要：探讨肝动脉栓塞化疗(TACE)联合自体细胞因子诱导的杀伤细胞(CIK)治疗原发性肝癌的临床疗效。比较TACE术+CIK组(治疗组)和TACE组(对照组)患者的免疫功能、临床疗效及副反应。结果表明,TACE术+CIK与TACE术比较安全有效。因此,TACE术联合自体CIK细胞是治疗原发性肝癌的一种有效方法。To investigate the clinical efficacy of TACE combined with autologous cytokine-induced killer（CIK） cells on hepatocellular carcinoma（HCC）.The immune function,clinical efficacy and side effects were compared between TACE＋CIK group（treatment group）and TACE group（control group）.The results show that TACE＋CIK was safe and effective compared with TACE.TACE combined with autologous CIK cells is an effective treatment method for HCC patients.

关 键 词：肝动脉栓塞化疗 CIK细胞 肝肿瘤 T淋巴细胞亚群 NK细胞 免疫功能 

分 类 号：R735.7[医药卫生—肿瘤]